Clinical trial
Sleep Disturbance, Depressive Symptoms, and Subsequent Quality of Life During Adjuvant Chemotherapy for Gastrointestinal Cancer
NCT06996483 is registered in ClinicalTrials.gov with Ankara Etlik City Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sleep Disturbance, Depressive Symptoms, and Subsequent Quality of Life During Adjuvant Chemotherapy for Gastrointestinal Cancer
- Lead sponsor
- Ankara Etlik City Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 30, 2025
- Completion date
- September 30, 2026
- Enrollment
- 198 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.